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Abstract To investigate prospectively, in patients
with suspicion of coronary artery disease (CAD), the
added value of coronary calcium scoring (CS) as
adjunct to cardiac magnetic resonance (CMR) for
the diagnosis of morphological coronary stenosis in
comparison to catheter angiography (CA). Sixty
consecutive patients (8 women; 64 ± 10 years)
referred to CA underwent CMR (1.5 T) including
perfusion and late gadolinium-enhancement imaging
as well as CS with computed tomography. Diag-
nostic performance was evaluated for CMR and CS
separately, and for both methods combined, with
CA as reference standard. Best CS threshold com-
bined with a specificity [90% to predict significant
stenosis in patients without abnormalities on CMR
was determined from receiver operator characteris-
tics (ROC) analysis. Abnormal CMR results were
considered to indicate significant stenosis regardless
of CS; CS above threshold reclassified patients to
have CAD regardless of CMR. CA identified 104/
960 (11%) coronary segments with coronary artery
stenosis [50% in 36/60 (60%) patients. ROC
revealed an area-under-the-curve of 0.83 (95%CI:
0.68-0.99) with the best CS threshold of 495
Agatston score (sensitivity 50%). CMR depicted
128/960 (13%) myocardial segments with abnor-
malities in 31/60 (52%) patients. Sensitivity, spec-
ificity, negative (NPV) and positive predictive value
(PPV) of CMR were 78, 88, 72 and 90%. When
adding CS to CMR, sensitivity and NPV increased
to 89 and 83%, while specificity and PPV slightly
decreased to 83 and 89%. Accuracy of the combined
approach (87%) was significantly (P \ 0.05) higher
than that of CMR (82%) alone. Adding CS to CMR
improves the accuracy for the detection of morpho-
logical CAD.
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Introduction
Myocardial perfusion imaging using cardiac mag-
netic resonance (CMR) represents a non-invasive
alternative imaging modality to catheter angiography
(CA) for the diagnostic and prognostic evaluation
of patients with suspected coronary artery disease
(CAD) [1, 2]. CMR is characterized by a good
diagnostic performance for the detection of CAD as
determined by CA [2, 3]. Myocardial perfusion
deficits however are not necessarily caused by
luminal stenosis only but microvascular obstruction
[4]. On the other hand, patients with epicardial
stenosis—in particular those with three-vessel disease
and balanced ischemia-may not be detected by using
CMR alone [5].
Recently, computed tomography (CT) has become
a valuable tool for assessing the morphology of
coronary arteries in patients with suspected CAD. In
addition, CT can also quantify the extent of coronary
calcifications by calcium scoring (CS) which is
performed without the administration of contrast
media and by using low radiation dose techniques.
CS allows for the diagnosis of early subclinical
atherosclerosis and improves risk stratification in
asymptomatic individuals [6, 7]. Recent data position
CS with CT as valuable test for improving the risk
stratification in patients having an intermediate risk
for CAD [4, 6, 7]. Although being characteristic in
CAD, arterial wall calcifications are not considered
an adequate hallmark for the identification of coro-
nary artery stenosis, different studies reported that
low CS thresholds are sensitive but not specific for
predicting coronary stenoses [8–10].
The aim of this study was to investigate prospec-
tively, in patients with suspicion of CAD, the added
value of CS as an adjunct to CMR for the diagnosis of
coronary atherosclerosis and particularly epicardial
coronary stenoses as determined by CA as the
standard of reference.
Methods
Study population
The study protocol was approved by the local
institutional review board; all patients gave written
informed consent before study enrollment.
The initial study group consisted of 65 consecutive
patients referred to CA who all had an intermediate
risk of having CAD based on the Diamond and
Forrester criteria [11]. Medical history including
cardiovascular risk factors, height, weight, blood
pressure, lipid profile, and a 12-lead electrocardio-
gram (ECG) was obtained from all patients.
Patients were excluded if they had contraindica-
tions for adenosine (second or third AV-block, sick
sinus syndrome, symptomatic bradycardia, severe
asthma or obstructive pulmonary disease; n = 4), or
to magnetic resonance imaging (implanted electronic
devices, metallic foreign bodies in the eye, severe
claustrophobia, and others according to local regula-
tions and manufacturer’s recommendations; n = 1).
Finally, a total of 60 patients (52 male, 8 female,
mean age 64 ± 10 years) were examined in this
study. The characteristics of the study population are
summarized in Table 1.
CMR and CS were performed on the same day.
The mean time interval between CA and CT/CMR
was 8 ± 3 days (range 1–13 days). The CMR and CS
results were not communicated to the interventional
cardiologist.
Catheter coronary angiography
Angiograms were obtained in at least two orthogonal
projections according to standard techniques. Coro-
nary angiograms of the target vessels were evaluated
Table 1 Patient demographics (n = 60)
Male patients 52 (87%)
Female patients 8 (13%)
Age (years) 64 ± 10 (41–85)
Body mass index (kg/m2) 27.4 ± 4.3
Obesitya 17 (28%)
Cardiovascular risk factors
Hypertension 46 (77%)
Nicotine abuse 20 (33%)
Hyperlipidemia 43 (72%)
Family history 11 (18%)
Diabetes 9 (15%)
Symptoms
Non-anginal pain or no chest pain 21 (35%)
Atypical angina 13 (22%)
Typical angina 26 (43%)
a Defined as a body mass index C30 kg/m2
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by consensus of two readers (with 6 and 8 years of
experience) who were blinded to CMR and CS results
but aware of the clinical history. Both examined each
catheter angiogram using computerized quantita-
tive coronary angiography (QCA) analysis software
(Xcelera, Philips Medical Systems, The Netherlands).
Coronary arteries were subdivided into 15 segments,
according to the scheme of the American Heart
Association (AHA) [12]. After averaging results from
two orthogonal projections, narrowing greater than
50% of the luminal diameter in relation to the
reference diameters was defined as morphological
stenosis.
CMR
All CMR studies were performed on a 1.5-T clinical
magnetic resonance system (Achieva, Philips Medi-
cal Systems, Best, The Netherlands) using standard-
ized protocols [13]. Dedicated cardiac phased-array
receiver coils were used for signal reception (five
elements). All data were acquired during breath hold
in end-inspiration. The true short-axis of the left
ventricle was determined from a series of long-axis
scout images. Three representative short-axis sections
were obtained, one each in the basal, mid-ventricular,
and apical region of the left ventricle according to the
standardized 17-segment model of the AHA [14].
Pharmacological stress using adenosine (Krenosin,
sanofi-aventis, Switzerland) was applied at 140 lg
per minute and kilogram of body weight over 3.0 min
under ECG, oxygen-saturation and blood pressure
monitoring. Injection of gadobutrolum (Gadovist 1.0;
Bayer Schering Pharma, Berlin, Germany) was started
at 2.5 min after the beginning of pharmological stress
with the acquisition of perfusion-CMR images.
Contrast media was administered at 0.1 mmol per
kg of body weight using a power injector (MR
Spectris; Medrad, Pittsburgh, Pa) at an injection rate
of 5.0 ml/s, followed by a 40-mL saline flush. Ten
minutes after stress perfusion imaging, a second
bolus of 0.1 mmol per kg of body weight followed by
saline flush was injected and rest perfusion images
were obtained with the same orientation and position
as in stress imaging. Prior-knowledge driven k–t
sensitivity encoding perfusion-CMR imaging was
used in combination with a saturation recovery
gradient-echo pulse sequence (repetition time/echo
time 3.1/1.1 ms; flip angle 20; saturation pre-pulse
delay 110 ms; partial Fourier sampling; acquisition
window 120 ms; section thickness 10 mm; k-t factor
of five with 11 k-t interleaved training profiles;
effective acceleration 3.7; three sections acquired
sequentially during a single R–R interval), as previ-
ously shown [15]. High-spatial resolution perfusion-
CMR was acquired with an in-plane resolution of
2.0 9 2.0 mm and reconstructed with an in-plane
resolution of 1.25 9 1.25 mm. Ten minutes after rest
perfusion, late gadolinium enhancement (LGE)
images were acquired in continuous short-axis view
using an inversion-recovery gradient-recalled echo
MR sequence with the following parameters: field of
view 350–400 mm; repetition time/echo time 7.4/
4.3 ms; inversion time 200–350 ms; flip angle 20;
matrix 240 9 240; slice thickness 10 mm. The
inversion time was optimized individually to null
the signal from normal myocardium.
All CMR images were evaluated visually on the
commercially available ViewForum (Philips, Best,
The Netherlands) by two experienced observers
(with 4 and 8 years of experience in cardiovascular
radiology) fully blinded to the clinical history, results
of CA, and additional test results including CS.
The myocardium of the apical section was divided
into four equiangular segments, and the equatorial
and basal sections were divided into six segments
according to the guidelines provided by the AHA and
the American College of Cardiology [14]. CMR
images were visually compared. Segmental perfusion
and LGE was scored with a 4-point scale (0 = def-
initely normal, 1 = probably normal, 2 = probably
pathological, 3 = definitely pathological), as previ-
ously shown [3, 15, 16]. A score of 2 and 3 was
considered abnormal in order to attain binominal
scoring. A segment was considered pathological if
either reduced peak signal intensity or delayed wash-
in compared to remote segments was shown at stress
but not at rest-perfusion or if LGE was present [17].
In case of disagreement between the readers, a
consensus reading was appended after 2 weeks.
CT calcium scoring
All CT examinations were performed on a dual-
source CT scanner (Somatom Definition, Siemens
Healthcare, Forchheim, Germany). A non-contrast
enhanced scan was performed for CS. The scan was
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performed in a cranio-caudal direction from the level
of the carina to the diaphragm. Data was acquired
using prospective ECG-triggering. Sequential scan-
ning was performed using the following parameters:
detector collimation, 2 9 32 9 0.6 mm; slice acqui-
sition, 2 9 64 9 0.6 mm by means of a z-flying spot;
gantry rotation time, 0.33 s; tube current time prod-
uct, 100 mA s/rotation; and tube potential, 120 kV.
Data acquisition was performed at 70% of the R–R
interval to reduce radiation exposure [18]. This CS
protocol resulted in an estimated effective radiation
dose of 1.1 ± 0.3 mSv. Image reconstruction was
performed using a mono-segment mode, with a
non-overlapping effective slice thickness of 3 mm
and a medium-soft-tissue convolution kernel (B35f).
Images were transferred to an external workstation
(Multi-Modality Workplace, Siemens) for further
analysis.
Calcifications were semi-automatically quantified
with scoring software (Syngo CaScore, Siemens) by a
single blinded experienced investigator using the
Agatston method [19]. On the basis of the total
Agatston score, patients were classified into five
categories, as previously reported [10]: CS B 10 (no
or minimal), 10 \ CS B 100 (mild), 100 \ CS B
400 (moderate), 400 \ CS B 1,000 (severe), CS
[ 1,000 (extensive). The CS-related risk of each
patient was stratified using age- and gender-related
percentiles [20]: patients with a CS B 25th percentile;
25th \ CS B 50th percentile; 50th \ CS B 75th per-
centile; 75th \ CS B 90th percentile; CS [ 90th
percentile.
Patients with a CS[75th percentile were classified
to be at high risk [20].
Statistics
Statistical analysis was performed with a commer-
cially available software package (SPSS release 17.0,
SSPS Inc., Chicago, IL, USA). Continuous variables
were expressed as mean ± 1SD, and categorical data
as frequencies and percentages.
Differences regarding demographic data (i.e.,
gender) between patients with and without coronary
artery stenosis were calculated using the Fisher exact
test and the Mann–Whitney U test for quantitative
variables (i.e., age, BMI), respectively. Cohen’s
kappa statistics were calculated for inter-observer
agreements with respect to CMR read-out.
Diagnostic accuracy and 95% confidence intervals
(CI) were calculated from contingency tables with
CA as the standard of reference. Statistics for
diagnostic accuracy of CMR, CS, and the combined
approach of CMR and CS were calculated on a per-
patient basis.
To investigate whether a high CS could be used to
detect morphological epicardial coronary artery ste-
nosis in the absence of perfusion deficits as deter-
mined by CMR, receivers operating characteristic
(ROC) curves along with the area under the curve
(AUC) were calculated. The best CS threshold was
determined as the cutoff point, which on ROC
analysis resulted in the best sensitivity for the
detection of stenosis with an associated specificity
of at least 90%.
This threshold was used to evaluate the diagnostic
accuracy of CMR alone and the combined approach
using the following rules (Fig. 1)
– Abnormal CMR results were considered as indi-
cating hemodynamically significant.
– In patients with normal CMR results, the CS was
taken into account. If the CS score in those
patients was above the cutoff defined by ROC
Fig. 1 Algorithm to evaluate diagnostic accuracy of CMR
alone and of the combined approach with CMR and CS. In case
of a perfusion defect in perfusion-CMR (CMR?), the patient
was rated as positive for CAD. In patients with normal CMR
(CMR-), CS was evaluated. If patients presented with a CS
score C 495, they were reclassified as positive for CAD;
otherwise they were rated as having no CAD
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analyses, patients were classified and considered
to have morphological coronary artery stenosis.
Difference in diagnostic accuracy for both
approaches (i.e. CMR alone and CMR combined
with CS) was tested for significance by using the
Wilcoxon signed rank test.
A P value of less than 0.05 (2-sided) was
considered statistically significant for all tests.
Results
There were no significant differences regarding
patient age (P = 0.37), gender (P = 0.55), and
BMI (P = 0.92) between patients with and without
coronary artery stenosis as determined by CA.
Catheter coronary angiography
QCA revealed 104/960 coronary segments (10.8%)
with stenosis in 36/60 patients (60%). Eighty-three of
the 180 vessels (46%) had at least one significant
coronary stenosis. The distributions of single-vessel,
2-vessel, and 3-vessel disease were 9 (25%), 7 (19%),
and 20 patients (56%), respectively. Left main
stenosis was not found in any patient.
CMR
Concerning all 960 myocardial segments, inter-
observer agreements for the assessment of perfusion
abnormalities were high for stress (kappa = 0.73)
and rest perfusion images (kappa = 0.82) as well as
for LGE (kappa = 0.84).
In CMR images, 128/960 myocardial segments
(13.3%) were categorized as abnormal in 31/60
patients (52%). All myocardial segments with LGE
(17/960; 1.8%) in 3/60 (1.7%) patients showed
corresponding perfusion-deficits. Visual analysis
revealed pathologic segments in 64/180 vessel terri-
tories (35.6%). Of the 64 defects, 25 (39%) were
allocated to the territory of the left anterior descending
artery, 18 (28%) were allocated to the left circumflex
artery, and 21 (33%) were allocated to the right
coronary artery territory, respectively. Twenty-nine
(48%) patients showed no abnormalities on CMR.
On a patient-based analysis, overall sensitivity of
CMR was 78%, specificity was 88%, PPV was 90%,
and NPV was 72% (Table 2).
CT calcium scoring
The heart rate during CT was 63 ± 9 beats per
minute. The CS could be determined in all 60 patients
(100%). The CS was 780 (range 0–4,433).
Ten of the 60 patients (17%) had no or minimal
CS, 6 (10%) had mild CS, 10 (17%) had moderate
CS, 15 (25%) had severe CS, and 19 (31%) had
extensive CS. Figure 2 demonstrates the percentage
of patients in each CS group together with coronary
stenoses as confirmed by CA (Fig. 2). Calcium
scoring-related percentiles stratified 31/60 (52%)
patients as having a CS beyond the 75th percentile.
Of the 29 patients without ischemia as determined by
CMR, 10/29 patients (34%) ranked above the 75th
percentile and were classified to be at high risk.
Using CS to identify epicardial stenosis as shown
by CA only, a CS of 495 yielded a sensitivity of 50%
and a specificity of 90% (AUC = 0.84; 95% CI:
0.70–0.99, Fig. 3).
Diagnostic accuracy of combined CS and CMR
A CS of C495 was determined as the best cutoff for
the detection of patients with epicardial coronary
stenosis but normal CMR. When this threshold was
used, the combination of data from CS and CMR
resulted in the reclassification of 4 of 8 patients (50%)
with negative CMR results (Fig. 4). CMR and CS
combined had a sensitivity of 89% and a specificity of
Table 2 Accuracy of CMR and the combination of CMR and CS for the detection of morphological coronary artery stenosis as
determined by quantitative coronary angiography
Sensitivity (CI; n)% Specificity (CI; n)% PPV (CI; n)% NPV (CI; n)% Accuracy (CI; n)%
Perfusion CMR 78 (63–93; 28/36) 88 (72–100; 21/24) 90 (78–100; 28/31) 72 (54–90; 21/29) 82 (71–92; 49/60)
CMR and CS 89 (77–97; 32/36) 83 (66–100; 20/24) 89 (77–100; 32/36) 83 (66–100; 20/24) 87 (77–96; 52/60)
NPV negative predictive value, PPV positive predictive value, CI 95% confidence interval
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83% for the detection of patients with epicardial
stenosis. Adding CS to CMR improved the sensitivity
of CMR from 78 to 89% (?11%) with a slight
decrease in specificity (from 88 to 83%; -5%). The
NPV increased from 72 to 83% (?11%) and the PPV
slightly decreased from 90 to 89% (-1%) for the
combined approach (Table 2). Diagnostic accuracy of
the combined approach (87%) for the detection of
morphological coronary stenoses was significantly
(P \ 0.05) higher than that of CMR alone (82%).
Discussion
Morphologic information obtained from CS as well
as functional information obtained from CMR pro-
vides complementary information on CAD as both
modalities investigate different pathophysiologic
aspects of CAD. We found that a CS of 495
represents the best cutoff for detecting patients with
morphological coronary stenosis in the absence of
functional CMR-deficits. When using this CS thresh-
old, the combination of CS and CMR outperformed
CMR alone in terms of sensitivity, NPV, and
accuracy in detecting patients with morphological
coronary stenosis as determined by CA.
Our per-patient based results for CMR (sensitivity/
specificity 78/88%) are in the range of data from a
recently published meta-analysis with sensitivities of
57–97% and specificities of 68–94% [2]. These
performance characteristics indicate that normal
perfusion on CMR does not exclude morphological
epicardial coronary stenosis as defined by CA.
CS reliably indicates coronary atherosclerosis and
reflects the total plaque burden [9] with a strong
predictive value for future cardiac events [6] prompt-
ing aggressive risk factor modification [6, 21]. In our
patient cohort 34% of patients without ischemia
on CMR were above the 75th percentile and there-
fore at high risk for subsequent cardiac events [22].
This information is important as previously published
reports have shown that CS data adds incremental
prognostic information and can subsequently refine
cardiac risk estimates within defined risk categories
[23, 24]. Hence, CS provides additional information
that cannot be obtained from functional testing alone
(27).
Combining both CS and CMR led to the reclassi-
fication of 50% of the patients as having
Fig. 2 Relationship between coronary artery calcification and
coronary artery disease. Bar chart demonstrating the relation-
ship between the extent of coronary artery calcification and
both the prevalence and severity of coronary artery disease
(CAD) as determined by quantitative coronary angiography
Fig. 3 ROC curve for the detection of morphological coronary
stenosis by calcium score. ROC curve adjusted for the coronary
artery calcium score for the detection of coronary stenosis
([50%) in patients with normal perfusion CMR results
(n = 29). An Agatston score C495 was defined as the best
threshold for detecting patients with coronary stenosis in the
absence of perfusion-deficits on CMR. AUC area under the
curve; CI confidence interval
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morphological epicardial stenoses despite normal
CMR results. Sensitivity, NPV, and accuracy
increased by 11, 11 and 5%, whereas specificity and
PPV slightly decreased by 5 and 1%. Hence, the
combination of both CMR and CS offers incremental
diagnostic information over perfusion CMR alone for
identifying patients with CAD. These results are in line
with recent studies employing CS together with single
photon emission CT [25], positron emission tomogra-
phy [26], and dobutamine stress CMR imaging [27]. In
these studies, CS contributed to the identification of
patients with CAD that were missed by functional
imaging alone. This fact might especially be pro-
nounced in patients with three-vessel disease and
balanced ischemia. Secondly, we may think that CS
potentially adds in the differentiation of real perfusion
deficits when image artifacts are present.
Generally, the a priori goal of noninvasive testing for
CAD is to refine prognostic assessment [6]. Adenosine
stress perfusion predicts a 3-year event-free survival of
99.2% for patients without perfusion abnormalities
[28]. Similarly to perfusion-CMR, CS is substan-
tially correlated with patient prognosis [6]. Elevated
CS predicted an annual ‘‘hard CAD’’ event rate of 2.8%
[7], whereas the absence of coronary calcium is
associated with a very low risk of developing future
cardiovascular events [29]. Thus, CS may also refine
prognosis of patients with an intermediate risk of CAD.
Although we believe adding CS to CMR improves
the diagnosis of morphological coronary stenosis and
prompts aggressive risk factor modification, we
would like to clarify that coronary stenosis should
only be treated when functional tests provide evi-
dence for hemodynamical significance [30].
Fig. 4 71-year-old male patient with epicardial stenosis of the
proximal left anterior descending artery (arrow) in CA (a).
Perfusion-CMR during adenosine stress (b) as well as during
rest (c) demonstrates normal myocardium without the evidence
of perfusion deficits; however, CS (d) classified this patient
having morpholocial coronary stenosis due calcifications
(arrows) resulting in an Agatston score of 709
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Radiation risk is a major factor that should be
considered in selecting the optimal diagnostic test for
a patient with suspected CAD. Thus, combined
evaluation by CS and CMR is advantageous for the
patients by delivering only very low radiation doses
in the range 1 mSv [6].
Study limitations
We used CA to determine if CAD was present in the
patient population, as did investigators in most
previous CMR studies [3, 15–17, 31]. If not com-
bined by functional measures such as the evaluation
of fractional flow reserve, CA does not represent an
ideal reference standard as it yields only an indirect
estimate of the flow limitation caused by coronary
stenosis. However, it is the most important clinical
reference examination, and the results of CA are
often the sole basis for further patient management. A
further limitation was the extraction of the best CS
threshold for detection of morphological epicardial
CAD from the same study population that was
subsequently analyzed. We did not incorporate
quantitative CMR evaluation in our evaluation pro-
tocol. However, most studies evaluating diagnostic
accuracy of CMR in the detection of CAD are
performed using purely visual evaluation of CMR [3,
16]. CS is prone to test-to-test variability and depends
on scanning parameters potentially limiting the
transferability of our threshold. Finally, presented
findings have to be confirmed in larger scale study
populations.
Conclusions
Adding CS to CMR in the non-invasive work-up of
patients with suspicious CAD improves the diagnosis
of morphological coronary stenosis. CS may also
prompt aggressive risk factor modification and thus
contribute to the patient management.
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